Clinical Trials › NCT04933552
Recruiting
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Sponsored by Novartis Pharmaceuticals
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 867
Target enrollment
1
U.S. states
Dec 2021
Start date
May 2032
Expected completion
Interventions / Treatments
Siponimod
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
California1 site
La Jolla
MS centers in California
Compare treatment centers near a trial site by center type, providers and trials.
View California centersThe app
Check out the MS Buddy app
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.